<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               1 INDICATIONS AND USAGE<BR>               <BR>                  FASLODEX is indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.<BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                        FASLODEX is an estrogen receptor antagonist indicated for the:<BR>                        <BR>                           <BR>                              â€¢Treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.<BR>                        <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>